Intervention, Nuclear Medicine and Immunotherapy for Anti-tumor

TAVO™

Orphan Drug Designation granted by the FDA
  • Trade Name: TAVO™
  • Indication: A tumor immunotherapy, which may stimulate the immune system to react under existing immunotherapeutic agents, for the treatment of unresectable metastatic melanoma, breast cancer and other tumors